Episode Details

In this episode of Global Economic Press, Alex Brady discusses a significant development in the field of integrative medicine with the launch of Europe's first physician-led ibogaine clinic by Ambio Life Sciences. Located in Malta, this new clinic marks a major milestone in the global expansion of psychedelic treatment options. Operated by Dr. Amir Chalaby and Dr. Emily Biesmans, the clinic introduces a new standard of ibogaine care in Europe, responding to the rising international demand for safe treatment. The facility offers Ambio's five-day Foundational Program, focusing on mental health challenges, traumatic brain injury, and personal optimization, with comprehensive medical oversight and therapeutic support.

The Malta clinic, situated on the scenic Mellieha Bay, provides a luxurious setting with private accommodations and somatic therapies designed to support recovery. This expansion makes ibogaine treatment more accessible to European, Canadian, and Eastern Seaboard clients, with direct flights available from major hubs. Emerging research suggests ibogaine could play a role in neuroregeneration and relief from complex conditions, as highlighted in a Stanford-affiliated study. Ambio Life Sciences, already operating five clinics in Mexico, continues to lead in providing gold-standard ibogaine care. For more information or to apply for treatment, visit the Ambio Life Sciences website.